It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
A new study found that your score on a key cardiovascular test may indicate your risk of dying in the coming years — even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback